AdaptHealth Signs Definitive Sale Agreement with Cardinal Health
Conshohocken, Pennsylvania, USA | July 20, 2026 AdaptHealth Corp. has entered into a definitive agreement to sell its Diabetes...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Conshohocken, Pennsylvania, USA | July 20, 2026 AdaptHealth Corp. has entered into a definitive agreement to sell its Diabetes...
INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...
ROME & CORAL GABLES, Fla., July 16, 2026 Angelini Pharma has completed its acquisition of Catalyst Pharmaceuticals, marking a...
DAYTON, Ohio, July 17, 2026 AmeriWater, a leading provider of water purification systems for critical healthcare applications, has announced...
ST. LOUIS and ROUEN, France, July 9, 2026 Stereotaxis announced the successful completion of its previously announced acquisition of...
HAVERHILL, United Kingdom, July 6, 2026 Codis announced an agreement to acquire Catalent Pharma Solutions’ Nottingham, UK facility, a...
SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, July 2, 2026 United Therapeutics Corporation has announced the acquisition...
BOSTON, Massachusetts, June 30, 2026 Skyhawk Therapeutics has announced encouraging 12-month interim results from its ongoing Phase 1/2 clinical...
SUZHOU, China, and MÖLNDAL, Sweden, July 2, 2026 Suzhou Ribo Life Science Co., Ltd. and its subsidiary Ribocure Pharmaceuticals...
FORT MYERS, Florida, July 2, 2026 Trilogy Laboratories has announced the acquisition of YNS Cosmeceuticals, a respected skincare brand...
